Psychedelics to Relieve Psychological Suffering Associated with a Life-Threatening Diagnosis: Time for a Canadian Policy Discussion.
Healthcare policy = Politiques de sante May 1, 2023 Sarah Kratina, Christopher Lo, Carol Strike et al. 8 citations
Canada is moving toward enabling access to therapeutic psychedelics. Federal initiatives now allow case-by-case requests for psychedelic-assisted therapies (PATs) to treat enduring and intolerable psychological suffering (EIPS) linked to life-threatening conditions. Renewed research, promising clinical trial results, public and media interest, and recognition of traditional Indigenous use have shifted the narrative around these stigmatized substances. The lack of access to PATs for EIPS, particularly at end of life, is presented as a public policy problem needing attention.